Overview

Dose Intralipid Infusion Reduces Pregnancy Complications Caused by Antiphospholipid Antibody Syndrome?

Status:
Withdrawn
Trial end date:
2021-05-31
Target enrollment:
Participant gender:
Summary
This study will address the value of adding intralipid infusion in reducing pregnancy complications related to antiphospholipid syndrome
Phase:
Phase 4
Details
Lead Sponsor:
Tanta University
Treatments:
Antibodies
Antibodies, Antiphospholipid
Aspirin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Soybean oil, phospholipid emulsion